CClinicalTrials.gg
Active, not recruitingNCT075961860150-24 SORUpdated May 19, 2026

Predict Early Cognitive Changes in a Healthy Elderly Population by Passively Recording Sensor Data From Mobile Devices

An observational study in Cognitive Decline, Mild, sponsored by Soroka University Medical Center. Active, not recruiting at 1 site in Israel. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by Soroka University Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
98
Ages
65 Years and older
Sex
All
01

Study summary

The study will recruit 100 participants aged 65+ residing in assisted living facilities. Eligible participants will undergo an initial cognitive assessment to document their baseline cognitive status using cognitive tests conducted either in their assisted living facility or at Soroka Medical Center. An app designed for research data collection (Aware-Light) will be installed on participants' mobile devices, collecting data only after participants provide consent. Over three months, the app will automatically gather sensor data, including movement data from the accelerometer, orientation data from the gravity sensor, rotation data from the gyroscope, proximity data for measuring distance from nearby objects, ambient light levels from the light sensor, and typing dynamics such as typing frequency and duration without recording actual text. The app will also track app usage, including activation, pauses, closures, background activity, notifications, and crashes, as well as air pressure through the barometer, phone capabilities through the telephony detector, and screen states such as on, locked, or off. It will log communication events such as calls and messages without recording personal details, monitor vehicle speed through the linear accelerometer, track rotation angles through the rotation detector, and identify significant movements like walking, cycling, or traveling. No typed data, such as passwords, will be collected. After one month, the research team will contact participants to ensure the app functions correctly. After three months, participants will undergo a second cognitive assessment, and the app will be uninstalled.

02

Conditions studied

  • Cognitive Decline, Mild

Keywords

  • Early Dementia
  • Mild Cognitive Decline
03

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Tenants in assisted living housing

Inclusion criteria

  • Age 65 and over
  • Clalit HMO members.
  • Without a known diagnosis of dementia
  • Uses Android mobile phones and writes text messages

Exclusion criteria

Exclusion Criteria:

  • A known diagnosis of dementia
  • Uses IOS mobile.
  • Doesn't write text messages
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
98 participants (actual)
Target follow-up
3 Months
Patient registry
Yes
05

What researchers measure

Primary outcomes

  1. Prediction model of mobile device data, collected for 9 months of lower scores in Neurotrax cognitive assessment compared to baseline evaluation.

    Mobile device sensor data

    Time frame: Baseline and 9 Month after

06

Study locations

1 site
  • Soroka Medical Center
    Beersheba, Israel
07

Registry details

Key details

Study ID
NCT07596186
Lead sponsor
Soroka University Medical Center
Responsible party
Gal Ifergane MD (Head of Neurology Department, Soroka University Medical Center) — Principal investigator
First posted
May 19, 2026
Start date
Dec 1, 2024
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
May 19, 2026

Study contacts

Gal Ifergane, MD-MHA
principal investigator · Soroka University Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion